The page is the record's research on the issuer — no analyst, no rating, no view.

# Prostatype Genomics AB (First North Sweden: SE0023261532) — research page

As of 2026-11-06 · se-cm-kg · record version 1

## Identity and listing

Prostatype Genomics AB is listed on First North Sweden under ticker SE0023261532, ISIN SE0023261532 and LEI 549300JO6MPCGPVHVU91. The record does not hold its security type, segment, sector or jurisdiction. Its listing status is listed, not halted.

## The disclosure read

The record holds 28 filings across 25 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 7.0 days, against a First North Sweden median of 11.0 days across 325 issuers. The latest filing is dated 2026-10-09 and is of type Other information disclosed according to the rules of the Exchange, 28 days before the record date of 2026-11-06. The latency median for First North Sweden is 7 days. The record does not hold a sector median for this market.

## Auditor

The record does not hold the auditor of record, its location, or any auditor changes.

## Events and halts

The record does not hold listing, delisting, name change, domicile change or segment move events, because the lifecycle type map for this register is not yet in place. The halt flag is not set: the issuer is listed, not halted.

## Orderability

The outcome is not determinable, because the chapter's orderability section carries no client categories for this market. The rule version is acm-68000/se/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.

## Coverage

The issuer's investor-relations page names 2 research houses: Aktiespararna and Redeye.

## Open research

The record holds 1 openly published research note, by Aktiespararna, dated 2024-05-01.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The market's vintage is not sealed. The record holds no sealed years for this issuer, no earliest sealed date for the market, and no live-record start date.

## Sources

8 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://firds.esma.europa.eu/firds/ (identity.exchange)
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- https://mcp.se-cm-kg.ai/events/SSME/SE0023261532 (the disclosure lines)
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- https://www.prostatypegenomics.com/investor-relations/analyst-coverage/ (coverage)
- https://storage.mfn.se/b311ab7d-a498-4824-9986-9a365e9226f9/reinitieringsanalys-prostatype-genomics-maj-2024.pdf (open research)
- https://mcp.se-cm-kg.ai/record/SSME/SE0023261532 (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/se/SSME/SE0023261532 · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp